Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page
- Check4 days agoChange DetectedUpdated the site revision from v3.3.3 to v3.3.4. No user-facing content or core functionality appears to be affected.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe Locations section has been expanded to list numerous study sites across the United States (AL, CA, CO, FL, GA, IN, KS, KY, MD, MI, MO, NY, OH, RI, TN, TX), Canada (AB, NB, ON, QC), Japan (Aichi-ken, Hiroshima, Hokkaido, Kanagawa, Osaka, Tokyo), and Spain (Catalonia, Valencia). The page revision also updates to v3.3.3.SummaryDifference2%

- Check54 days agoChange DetectedThe page shows a new revision label: Revision: v3.3.2, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedRemoved the government funding and NIH operating status notice from the page; to avoid being alerted by small changes, set an alert condition by clicking below. Other study details remain unchanged.SummaryDifference0.2%

- Check76 days agoChange DetectedNo significant content changes detected; observed differences appear to be minor visual adjustments and updated timestamps. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check104 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.